Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Mosapride and Rebamipide in Healthy Volunteers
NCT02106130Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- May 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of mosapride and rebamipide in gastritis and functional dyspepsia (FD) (4 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Curve over the dosing interval at steady state and Maximum Plasma Concentration at steady state. Started May 2013; status: completed.
02
Drugs
mosapriderebamipide
03
Conditions
gastritisfunctional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02106130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106130.